Expression of HER2 and its association with AP-2 in breast cancer
- 31 July 2004
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (10), 1485-1495
- https://doi.org/10.1016/j.ejca.2004.02.020
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Update on HER-2 as a target for cancer therapy: The ERBB2 promoter and its exploitation for cancer treatmentBreast Cancer Research, 2001
- The EGFR family and its ligands in human cancerEuropean Journal Of Cancer, 2001
- Overexpression of HER2/neu in solid tumours: an immunohistochemical surveyHistopathology, 2001
- Overexpression of ErbB2 in cancer and ErbB2-targeting strategiesOncogene, 2000
- The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand‐receptor interactionsFEBS Letters, 1997
- Neuregulins and Their Receptors: A Versatile Signaling Module in Organogenesis and OncogenesisNeuron, 1997
- ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signalingThe EMBO Journal, 1997
- A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines.The EMBO Journal, 1993
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987